Long-term Eculizumab Treatment Contributes to Recovery from End-stage Renal Disease Caused by Atypical Hemolytic Uremic Syndrome

We experienced a favorable outcome in an adult case of atypical hemolytic uremic syndrome (aHUS) after long-term eculizumab treatment. A 38-year-old Japanese man with a history of central retinal vein occlusion was admitted to our hospital with progressive dyspnea. He was found to have non-immune he...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamada, Yuji, Abe, Ryohei, Okano, Yutaka, Miyakawa, Yoshitaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478572/
https://www.ncbi.nlm.nih.gov/pubmed/28458317
http://dx.doi.org/10.2169/internalmedicine.56.7862

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478572/
https://www.ncbi.nlm.nih.gov/pubmed/28458317
http://dx.doi.org/10.2169/internalmedicine.56.7862

Ejemplares similares